Healthcare Equipment and Supplies
Company Overview of MicroCHIPS, Inc.
MicroCHIPS, Inc. develops and tests intelligent implantable drug delivery devices and biosensors for people with chronic conditions. The company offers a delivery device for PTH(1-34)/teriparatide, an anabolic agent for the treatment of osteoporosis to deliver precise doses at prescribed intervals and overcome the compliance limitations associated with injectable drug delivery. It also provides Continuous Glucose Monitor, a long-term implanted monitor for diabetes to wirelessly deliver continuous glucose measurements. The company was incorporated in 1999 and is headquartered in Lexington, Massachusetts.
128 Spring Street
Lexington, MA 02421
Founded in 1999
Key Executives for MicroCHIPS, Inc.
Chief Executive Officer and Director
President and Chief Operating Officer
Compensation as of Fiscal Year 2014.
MicroCHIPS, Inc. Key Developments
MicroCHIPS, Inc. Presents at Boston Biotech Conferences LLC's The East Meets West CEO conference, Jan-11-2015 02:10 PM
Jan 9 15
MicroCHIPS, Inc. Presents at Boston Biotech Conferences LLC's The East Meets West CEO conference, Jan-11-2015 02:10 PM. Venue: Four Seasons Hotel, 757 Market St, San Francisco, CA 94103. Speakers: Cheryl R. Blanchard, Chief Executive Officer and Director.
MicroCHIPS, Inc. Presents at 13th Annual BIO Investor Forum, Oct-08-2014 09:00 AM
Sep 12 14
MicroCHIPS, Inc. Presents at 13th Annual BIO Investor Forum, Oct-08-2014 09:00 AM. Venue: The Palace Hotel, San Francisco, CA 94105, United States. Speakers: Cheryl R. Blanchard, Chief Executive Officer and Director.
MicroCHIPS, Inc. Announces Management Changes
Jul 21 14
MicroCHIPS, Inc. announced that its Board of Directors has appointed Cheryl R. Blanchard, Ph.D., as Chief Executive Officer and member of the Board of Directors effective immediately. Blanchard was formerly Senior Vice President and Chief Scientific Officer of Zimmer, Inc. Blanchard joins MicroCHIPS at a time when the company is preparing for the next stage of commercialization for its implantable drug delivery devices, with a near-term focus on applications for women's health. As the former chief scientific officer and general manager of the biologics business at a global medical device company, Cheryl brings a skill set critical for MicroCHIPS to commercialize its products. Blanchard replaces Bradley W. Paddock, who was appointed interim CEO in December 2013. He has accepted a role as General Manager, Stryker Spine. Blanchard has extensive experience in the medical device and biologics sectors. For the past 12 years, Blanchard served in roles of increasing responsibility at Zimmer, Inc. Her roles at Zimmer included leadership of research and development, clinical, quality and regulatory affairs, and health economics. She was also a member of Zimmer's executive committee and developed and led the biologics business at Zimmer through disciplined execution of an R&D pipeline coupled with significant partnering and business development activities.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|